INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2008

In a crossover trial, ANP infusion reduced postprandial blood pressure while increasing lipolysis, lipid oxidation rates, and energy expenditure after a meal.

Twelve men received an infusion of human ANP (25 ng/kg/min) or placebo before, during, and 2 hours after a standardized high-fat test meal in a randomized, double-blind, crossover study. ANP infusion decreased mean arterial blood pressure by 4 mmHg during the postprandial phase compared with placebo (P < 0.01). ANP also induced lipolysis systemically (P < 0.05) and locally in subcutaneous abdominal adipose tissue (P < 0.0001), resulting in a 50% increase in venous glycerol (P < 0.01) and free fatty acid concentrations (P < 0.05). Furthermore, ANP led to a 15% increase in lipid oxidation rates and a substantial increase in postprandial energy expenditure (both P < 0.05 vs. placebo).

Study type
Randomized, double-blind, crossover trial
Who was studied
12 men (age 32 +/- 0.8 years, BMI 23.3 +/- 0.4 kg/m2)
What was measured
Mean arterial blood pressure, lipolysis, free fatty acids, lipid oxidation rates, and postprandial energy expenditure

THE PAPER

Atrial natriuretic peptide induces postprandial lipid oxidation in humans.

Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, Berlan M, Marques MA, Sweep FC, Luft FC, Lafontan M, Jordan J. Diabetes, 2008.

PubMed 18835931 ↗DOI 10.2337/db08-0649 ↗

Heart & arteriesBlood pressureWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.